Zobrazeno 1 - 10
of 16
pro vyhledávání: '"See WL"'
Autor:
DiNardo, CD, de Botton, S, Risueño, A, Schuh, AC, Löwenberg, B, Kim, HJ, Vyas, P, Wei, AH, Stein, EM, Döhner, H, Fathi, AT, Martin-Regueira, P, Taningco, L, Bluemmert, I, Yu, X, See, WL, Hasan, M
Publikováno v:
Clinical Lymphoma, Myeloma and Leukemia, 22, S249-S250. Cancer Media Group
Context : IDH2 mutations (mIDH2) occur in ~8%-19% of patients with AML, typically as R140Q (~75%) or R172K (~25%) point mutations, which have distinct functional effects and prognostic relevance. In the phase 3 IDHENTIFY trial, enasidenib did not sig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5183316e221f63004b35c95a9e4c6cdb
https://ora.ox.ac.uk/objects/uuid:ad598452-c6c2-4a77-a80c-48012bd4f2c7
https://ora.ox.ac.uk/objects/uuid:ad598452-c6c2-4a77-a80c-48012bd4f2c7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Risueño A; Bristol Myers Squibb, Lawrenceville, 3401 Princeton Pike, Lawrence Township, NJ 08648, United States., See WL; Bristol Myers Squibb, Summit, 86 Morris Avenue, Summit, NJ 07901, United States., Bluemmert I; Celgene International Sàrl, a Bristol-Myers Squibb Company, Route de Perreux 1, Boudry 2017, Switzerland., de Botton S; Institut Gustave Roussy, 114 Rue Edouard Vaillant, Villejuif 94805, France., DiNardo CD; The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States., Fathi AT; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, United States., Schuh AC; Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON M5G 2C4, Canada., Montesinos P; Hospital Universitario y Politécnico La Fe, Avinguda de Fernando Abril Martorell, 106, Valencia 46026, Spain., Vyas P; MRC Molecular Haematology Unit and Oxford Biomedical Research Centre, University of Oxford and Oxford University Hospitals, Headley Way, Headington, Oxford OX3 9DS, United Kingdom., Prebet T; Bristol Myers Squibb, Summit, 86 Morris Avenue, Summit, NJ 07901, United States., Gandhi A; Bristol Myers Squibb, Summit, 86 Morris Avenue, Summit, NJ 07901, United States., Hasan M; Bristol Myers Squibb, Summit, 86 Morris Avenue, Summit, NJ 07901, United States. Electronic address: maroof.hasan@bms.com.
Publikováno v:
Leukemia research [Leuk Res] 2024 May; Vol. 140, pp. 107497. Date of Electronic Publication: 2024 Mar 27.
Autor:
See WL; Predoctoral student, Division of Restorative Dentistry, School of Dentistry, IMU University, Kuala Lumpur, Malaysia., Khoo TL; Predoctoral student, Division of Restorative Dentistry, School of Dentistry, IMU University, Kuala Lumpur, Malaysia., Mohan M; Senior Lecturer in Prosthodontics, Division of Restorative Dentistry, School of Dentistry, IMU University, Kuala Lumpur, Malaysia., Nimbalkar S; Lecturer in Orthodontics, Division of Oral Health Sciences, School of Dentistry, IMU University, Kuala Lumpur, Malaysia., Patil PG; Lecturer in Prosthodontics, Division of Restorative Dentistry, School of Dentistry, IMU University, Kuala Lumpur, Malaysia. Electronic address: pravinandsmita@yahoo.co.in.
Publikováno v:
The Journal of prosthetic dentistry [J Prosthet Dent] 2024 Apr 22. Date of Electronic Publication: 2024 Apr 22.
Autor:
Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Döhner H; Ulm University Hospital, Ulm, Germany., Wei AH; Peter MacCallum Cancer Centre, Melbourne, Australia.; The Royal Melbourne Hospital, Melbourne, Australia., Montesinos P; Hematology Department, Hospital Universitari i Politècnic, La Fe, València, Spain.; CIBERONC, Instituto Carlos III, Madrid, Spain., Pfeilstöcker M; Third Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Papayannidis C; IRCCS, Azienda Ospedaliero Universitaria di Bologna, Istituto di Ematologia 'L. e A. Seràgnoli', Bologna, Italy., Lai Y; Bristol Myers Squibb, Princeton, New Jersey, USA., Wang K; Bristol Myers Squibb, Princeton, New Jersey, USA., See WL; Bristol Myers Squibb, San Francisco, California, USA., de Menezes DL; Bristol Myers Squibb, San Francisco, California, USA., Petrlik E; Bristol Myers Squibb, Princeton, New Jersey, USA., Prebet T; Bristol Myers Squibb, Summit, New Jersey, USA., Roboz GJ; Weill Cornell Medicine, New York, New York, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Mar; Vol. 204 (3), pp. 877-886. Date of Electronic Publication: 2023 Nov 12.
Autor:
Menezes DL; Bristol Myers Squibb, San Francisco, California, USA., See WL; Bristol Myers Squibb, San Francisco, California, USA., Risueño A; Bristol Myers Squibb, Lawrenceville, New Jersey, USA., Tsai KT; Bristol Myers Squibb, Summit, New Jersey, USA., Lee JK; Bristol Myers Squibb, Lawrenceville, New Jersey, USA., Ma J; Bristol Myers Squibb, Summit, New Jersey, USA., Khan R; Bristol Myers Squibb, Summit, New Jersey, USA., Prebet T; Bristol Myers Squibb, Summit, New Jersey, USA., Skikne B; Bristol Myers Squibb, Summit, New Jersey, USA.; University of Kansas Medical Center, Kansas City, Kansas, USA., Beach CL; Bristol Myers Squibb, Summit, New Jersey, USA., Thakurta A; Bristol Myers Squibb, Summit, New Jersey, USA., Gandhi A; Bristol Myers Squibb, Summit, New Jersey, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2023 Jun; Vol. 201 (6), pp. 1129-1143. Date of Electronic Publication: 2023 Mar 29.
Autor:
Wei AH; Department of Clinical Haematology, The Alfred Hospital, Melbourne, Victoria, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia., Döhner H; Ulm University Hospital, Ulm, Germany., Sayar H; Indiana University Cancer Center, Indianapolis, Indiana, USA., Ravandi F; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Montesinos P; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Dombret H; Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France., Selleslag D; AZ Sint-Jan Brugge-Oostende AV, Bruges, Belgium., Porkka K; HUS Comprehensive Cancer Center, Hematology Research Unit Helsinki and iCAN Digital Precision Cancer Center Medicine Flagship, University of Helsinki, Helsinki, Finland., Jang JH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Skikne B; University of Kansas Cancer Center, Kansas City, Kansas, USA.; Bristol Myers Squibb, Summit, New Jersey, USA., Beach CL; Bristol Myers Squibb, Summit, New Jersey, USA., Prebet T; Bristol Myers Squibb, Summit, New Jersey, USA., Zhang G; Bristol Myers Squibb, Summit, New Jersey, USA., Risueño A; BMS Center for Innovation and Translational Research Europe (CITRE, a Bristol-Myers Squibb Company), Seville, Spain., Ugidos M; BMS Center for Innovation and Translational Research Europe (CITRE, a Bristol-Myers Squibb Company), Seville, Spain., See WL; Bristol Myers Squibb, Summit, New Jersey, USA., Menezes D; Bristol Myers Squibb, Summit, New Jersey, USA., Roboz GJ; Weill Cornell Medicine, New York, New York, USA.; New York Presbyterian Hospital, New York, New York, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2023 Apr; Vol. 98 (4), pp. E84-E87. Date of Electronic Publication: 2023 Feb 06.
Autor:
Döhner H; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Wei AH; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.; Department of Clinical Haematology, The Alfred Hospital, Melbourne, Australia., Roboz GJ; Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY.; Division of Hematology & Medical Oncology, New York Presbyterian Hospital, New York, NY., Montesinos P; Servicio de Hematología y Hemoterapia, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Thol FR; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Medizinische Hochschule Hannover, Hannover, Germany., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Dombret H; Leukemia Unit, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Institut de Recherche Saint Louis, Université de Paris, Paris, France., Porkka K; Hematology Research Unit Helsinki, HUS Comprehensive Cancer Center, and iCAN Digital Precision Cancer Center Medicine Flagship, University of Helsinki, Helsinki, Finland., Sandhu I; Department of Oncology, University of Alberta, Edmonton, AB, Canada., Skikne B; University of Kansas Medical Center, Kansas City, KS.; Bristol Myers Squibb, Princeton, NJ., See WL; Translational Medicine, Bristol Myers Squibb, Summit, NJ., Ugidos M; BMS Center for Innovation and Translational Research Europe (CITRE), a Bristol-Myers Squibb Company, Seville, Spain., Risueño A; BMS Center for Innovation and Translational Research Europe (CITRE), a Bristol-Myers Squibb Company, Seville, Spain., Chan ET; Bristol Myers Squibb, Princeton, NJ., Thakurta A; Translational Medicine, Bristol Myers Squibb, Summit, NJ., Beach CL; Bristol Myers Squibb, Princeton, NJ., Lopes de Menezes D; Translational Medicine, Bristol Myers Squibb, Summit, NJ.
Publikováno v:
Blood [Blood] 2022 Oct 13; Vol. 140 (15), pp. 1674-1685.
Autor:
MacBeth KJ; Bristol Myers Squibb, Princeton, NJ. Electronic address: kjmacbeth@gmail.com., Chopra VS; Bristol Myers Squibb, Princeton, NJ., Tang L; Bristol Myers Squibb, Princeton, NJ., Zheng B; Bristol Myers Squibb, Princeton, NJ., Avanzino B; Bristol Myers Squibb, Princeton, NJ., See WL; Bristol Myers Squibb, Princeton, NJ., Schwickart M; Bristol Myers Squibb, Princeton, NJ., Figueroa ME; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL., Quek L; MRC Molecular Hematology Unit, WIMM University of Oxford, Oxford, UK., DiMartino JF; Bristol Myers Squibb, Princeton, NJ.
Publikováno v:
Experimental hematology [Exp Hematol] 2021 Jun; Vol. 98, pp. 47-52.e6. Date of Electronic Publication: 2021 Mar 29.
Autor:
Stein EM; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address: steine@mskcc.org., Fathi AT; Massachusetts General Hospital Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., DiNardo CD; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pollyea DA; Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA., Roboz GJ; Weill Cornell Medical College, New York, NY, USA; New York Presbyterian Hospital, New York, NY, USA., Collins R; University of Texas Southwestern Medical Center, Dallas, TX, USA., Sekeres MA; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA., Stone RM; Dana Farber Cancer Institute, Boston, MA, USA., Attar EC; Agios Pharmaceuticals, Cambridge, MA, USA., Frattini MG; Celgene, Summit, NJ, USA., Tosolini A; Celgene, Summit, NJ, USA., Xu Q; Celgene, Summit, NJ, USA., See WL; Celgene, Summit, NJ, USA., MacBeth KJ; Celgene, Summit, NJ, USA., de Botton S; Département d'Hématologie et Département d'Innovation Thérapeutique, Gustave Roussy, Villejuif, France; Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France., Tallman MS; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA., Kantarjian HM; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2020 Apr; Vol. 7 (4), pp. e309-e319. Date of Electronic Publication: 2020 Mar 05.